Background: Bone-anchored hearing aids (BAHAs) are indicated for people with conductive or mixed
This paper summarises the results of the systematic review of clinical effectiveness conducted as part of a project commissioned by the UK National Institute for Health Research Health Technology Assessment programme. 9 
Methods

Search strategy
Nineteen electronic databases, including MEDLINE, EMBASE and The Cochrane Library, were searched from their inception to November 2009 for published and ongoing studies, with no language restrictions (full details of the search strategy are available elsewhere 9 ). Additional references were identified from bibliographies of retrieved articles, experts and BAHA manufacturers.
Evaluation method
Two reviewers independently screened studies for inclusion according to predefined criteria:
• Population: children or adults with bilateral hearing impairment;
• Intervention: BAHA (fitted unilaterally or bilaterally);
• Comparisons: BAHA versus bone-conduction hearing aids, air-conduction hearing aids, unaided hearing or ear surgery; unilateral BAHAs versus bilateral BAHAs;
• Outcomes: audiometric thresholds, aided audiometric thresholds (pure-tone and warble tone), speech recognition scores, validated measures of quality of life and patient satisfaction, adverse events;
• Study design: Prospective controlled studies, prospective one group before-and-after studies, crosssectional 'audiological comparison' studies, prospective case series (no comparator condition). Only studies with the most rigorous designs were included for each comparison. Where higher level evidence was limited to BAHA models no longer in current use, lower level evidence for models in current use was considered.
Data extraction and quality assessment were undertaken by one reviewer and checked by a second reviewer.
A flowchart showing the number of references excluded at each stage of screening is shown in Figure 1 .
Twelve studies (reported in 15 publications) were included in the systematic review. The included studies were either one group cohort before-and-after studies or cross sectional 'audiological comparison' studies.
Only two studies included BAHA models that are in current use. 11, 12 No eligible studies comparing BAHAs with ear surgery were identified.
Twenty-eight potentially relevant non-English language papers were identified (list available elsewhere 9 ).
Examination of the titles and English abstracts (where available) suggested none had a concurrent control group and it was unclear whether any of the studies met the inclusion criteria. Due to the limited value it was anticipated these studies would add to the review and in view of limited resources, these studies were not assessed further.
Characteristics of included studies are presented in Table 1 . All 12 included studies were rated overall as 'weak' for their methodological quality and quality of reporting, providing the opportunity for bias (see Table S1 for a summary of methodological quality). The types of biases apparent in some of the studies include selection bias (participants may not be representative of the target population); performance bias (bias in the care provided); measurement or detection bias (how outcomes are assessed); and attrition bias (bias in withdrawals and dropouts). Any observed treatment effects could be due to bias, or a treatment effect could be obscured by bias. These biases could lead to overestimation or underestimation of the true effect.
BAHAs versus bone-conduction hearing aids
Four cohort before-and-after studies [13] [14] [15] [16] [17] [18] included a comparison of BAHAs and bone-conduction hearing aids (Table 2) . Improvements in the average sound field pure-tone or warble tone thresholds were found with a BAHA by two studies, 13, 14 but statistical analysis was reported by only one of these (p<0.01). 14 A third study did not report thresholds averaged across frequencies, but found improved thresholds with the boneconduction hearing aid at 0.25 kHz and 0.5 kHz, and with the BAHA at higher frequencies. 16 No statistical analysis was undertaken.
Speech discrimination tests varied between the studies (Table 2) . A statistically significant improvement in speech reception threshold in quiet was found in people with a sensorineural loss of less than 30 dB HL.
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Another study found no statistically significant difference in sound field speech discrimination scores.
14 Statistical analyses were not reported for other results from the included studies (Table 2) .
Two studies reported using a validated measure of quality of life, 13, 15 although limited data were presented by one of the studies 13 (see Table S2 for a summary of quality of life scores). The second study found no statistically significant differences between bone-conduction hearing aids and BAHAs using the 36-Item Short-Form Health Survey (SF-36) and European Quality of Life-5 Dimensions (EQ-5D), however a statistically significant improvement with a large clinical impact was found for handicap and disability with the Hearing Handicap and Disability Index. 15 The number of otolaryngology visits over the preceding six months for draining ears was reported by one study, which found these to reduce from a mean of 5. should be taken when interpreting results due to the issues associated with non-validated questionnaires.
BAHAs versus air-conduction hearing aids
Five cohort before-and-after studies [14] [15] [16] [17] [18] [19] [20] and one cross-sectional study 11 included a comparison of BAHAs and air-conduction hearing aids (Table 3 ). The direction of effect for sound-field pure tone or warble tone thresholds was inconsistent between the five studies reporting hearing threshold data. Two studies reported a statistically significant improvement in mean sound field warble tone thresholds, 11,14 whilst another study described their data on average warble tone thresholds (0.2 to 4 kHz) as 'comparable' between BAHAs and air-conduction hearing aids, but did not provide statistical analysis. 19 Three studies presented thresholds at each frequency individually, but there was no clear pattern as to the comparative benefits of air-conduction hearing aids and BAHAs. 11, 16, 20 The direction of the effect was also unclear for speech audiometry, with some studies finding better outcomes with the air-conduction hearing aid and some with the BAHA. A variety of different test protocols were used by the studies. Two studies reported better outcomes with the air-conduction hearing aid for mean sound field speech discrimination scores, 19 or for maximum phoneme score and speech recognition threshold. 16 However, statistical analysis was not conducted (Table 3) . A later publication with a different patient group (less severe hearing loss), found a statistically significant decrement in mean speech reception threshold in quiet with the BAHA (p<0.05), but a statistically significant improvement in discrimination of speech in background noise (as measured by speech to noise ratio, p<0.05). 18 One study found no statistically significant difference in the maximum phoneme score, but a statistically significant improvement in speech in noise ratio with the BAHA. 20 Speech discrimination scores were statistically significantly better with the BAHA in the congenital aetiology group, but not the chronic suppurative otitis media group in one study. 14 The final study reported an improvement with the BAHA in speech understanding in noise described as 'large and clinically significant' in participants with mixed hearing loss.
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One study reported using a validated measure of quality of life, which was assessed using an air-conduction hearing aid prior to BAHA surgery and again after six months experience with a BAHA 15 (see Table S3 for a summary of quality of life scores). A statistically significant increase in anxiety/depression with BAHAs was found by the EQ-5D, but the clinical effect was small. No other statistically significant differences were found between air-conduction hearing aids and BAHAs by the EQ-5D or the SF-36, however a statistically significant improvement with a large clinical impact was found for handicap and disability with the Hearing
Handicap and Disability Index. 15 The number of otolaryngology visits over the preceding six months for draining ears was reported by one 
BAHAs versus unaided hearing
Four cohort before-and-after studies [12] [13] [14] 19 included a comparison of BAHAs with unaided hearing (Table 4 ).
All four studies found improvements in sound field thresholds (pure-tone or warble tone) with the BAHA compared with unaided hearing thresholds, and these improvements were statistically significant in the two studies that conducted analysis. 12, 14 Improvements were found in sound field speech discrimination scores, 14, 19 speech recognition scores, 12 speech recognition threshold in quiet 12 and speech recognition in noise. 12 However, statistical analysis was not undertaken (Table 4) . No self-report measures were reported by these four studies.
Unilateral versus bilateral BAHAs
Four cross sectional studies 3,5,21-23 compared performance on audiological measures with unilateral versus bilateral BAHAs (Table 5 ). The participants in the included studies all underwent sequential (separate operations) implantation of the bilateral BAHAs.
Two studies reported data on hearing thresholds. Sound-field average tone thresholds were improved with bilateral BAHAs compared with unilateral BAHAs in adults 23 and a small group (n=3) of children 3 with previous experience of bilateral BAHAs, but statistical analysis was not undertaken (Table 5) .
Two studies found speech recognition thresholds in quiet were statistically significantly better with bilateral BAHAs 5,23 (Table 5) . Another study found all 11 participants scored 100% with right, left and bilateral
BAHAs for sound field speech in quiet.
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Different tests of speech in noise demonstrated that bilateral BAHAs produced better results than one BAHA when noise was presented from baffle/better hearing side (the side with the BAHA in the unilateral condition), but not when noise was presented from the shadow side (the side opposite to the BAHA in the unilateral condition). 5, 22, 23 Three studies demonstrated that sound localisation abilities were improved with bilateral BAHAs. 3, 5, 23 Correct localisation, localisation within 30˚ and lateralisation measured at 0.5 kHz and 2 kHz were significantly better than chance with bilateral BAHAs, but not with unilateral BAHAs, in the study by
Bosman and colleagues. Bilateral BAHAs performed statistically significantly better than unilateral BAHAs. 5, 21 (Table 5 ).
Priwin and colleagues found similar results in their studies of twelve adults 23 and nine children, 3 although no statistical analyses were undertaken. In the first study, accuracy of sound localisation with a unilateral BAHA on the best or shadow side were close to the chance level, while with a bilateral BAHA the accuracy improved. Similarly, the second study found an improvement in sound localisation and sound lateralisation abilities with bilateral BAHAs, while with unilateral BAHAs the results were close to chance levels 3 (Table   5 ). Two studies used the binaural masking level difference test to suggest that BAHAs give binaural hearing. 5, 23 However, it has been argued that the interpretation of some listening tests with bilateral BAHAs is complex, due to effects arising from cross hearing, and is currently incomplete (see Rowan & Gray 2008   24 for background on these issues).
One study 3 described self-report measures using validated tools to assess hearing skills in 'meaningful, real world situations' and hearing aid outcomes (see Table S4 ). Scores appeared similar between unilateral and bilateral BAHA users for most items, however given the very small sample sizes (n=2 to n=6), these results should be interpreted with caution.
Adverse events
Only three of the included studies reported minimal data on adverse events 13, 18, 20 (Table 6 ), therefore additional data from prospective case series were sought. It should be noted that these studies did not undergo the same process of data extraction and quality assessment. Five prospective case series were identified 25-29 (see Table S5 for a summary of these studies) and reported loss of implants between 6.1% (9 to 25 months follow-up) 28 and 19.4% (median 6 years follow-up). 25 The vast majority of participants in the prospective case series experienced no or minor skin reactions.
Discussion
Clinical applicability of the study
Whilst the evidence base is not strong, it appears that when applied to bilateral conductive or mixed hearing loss, audiometric outcomes from BAHA are good and adverse events are rarely reported. Based on the available evidence BAHAs are a reasonable treatment option for consideration by health care commissioners, clinicians and patients, however further research would reduce the uncertainties regarding BAHAs.
Synopsis of key findings
The findings of this review suggest that hearing is improved with BAHAs compared with unaided hearing, and while there appear to be some audiological benefits of BAHAs when compared with conventional boneconduction hearing aids, the limited evidence base does not provide a reliable estimate of the degree of benefit. The audiological benefits of BAHAs when compared with air-conduction hearing aids are less clear.
Limited data suggest an improvement in quality of life with BAHAs when compared with conventional aids, but this was identified by the hearing-specific instrument and not generic quality of life measures. There is an absence of reliable evidence regarding other potential benefits, such as length of time the aid is able to be worn and improvement of discharging ears. The evidence suggests there are some benefits of bilateral
BAHAs compared with unilateral BAHAs in many, but not all, situations, and the presence of binaural hearing with bilateral BAHAs remains uncertain.
Comparisons with other studies
These findings are broadly in line with those of a previous systematic review, 30 which assessed the nonacoustic (self-report generic and disease-specific quality of life) benefits of BAHAs. The authors of the previous review concluded that there is limited statistically supported, empirically controlled evidence supporting the nonacoustic benefits of BAHAs relative to more conventional hearing aids or no hearing aids at all. However, the previous review was limited to nonacoustic outcomes and no other systematic reviews of BAHAs for bilateral hearing loss were identified.
Strengths and limitations of the systematic review
This systematic review brings together the evidence for the clinical effectiveness of BAHAs for people with bilateral hearing impairment. This evidence has been critically appraised and presented in a consistent and transparent manor following the principles for conducting as systematic review. The methods were set out in a research protocol which defined the research question, inclusion criteria, data extraction and quality assessment process and methods to be employed at different stages of the review. The conclusions drawn from the present systematic review are constrained by the limitations of the available evidence. Despite a wide ranging and systematic search, no prospective trial with a concurrent control group was identified.
There is a high risk of bias in the included studies. Synthesis of the included studies was through narrative review as differences in participants, comparator and outcome measures meant that meta-analysis was inappropriate. No prospective study comparing BAHAs with ear surgery was identified, therefore no conclusions could be drawn. The non-English language references identified by the searches were not translated and screened. However, none of these papers appeared to present higher level evidence and it is unlikely that the inclusion of additional lower level evidence would change the conclusions of this review.
The studies reviewed date from the inception of BAHAs to November 2009 (date of the literature searches).
During that time period the hearing aid sound processing technology used was essentially a single channel analog design; however devices that utilise new sound processing technology have recently been released to market by different manufacturers. Research reports indicating improved audibility with such technology are beginning to appear in the conference literature, but whilst these devices are more adaptable, and that may bring some incremental improvement in performance in some users, the candidacy criteria for or speech reception levels in quiet have often been applied, but may not be sufficiently sensitive to capture the benefit delivered to the individual. We acknowledge that this review has somewhat simplified the interpretation of outcomes, where we have assumed that lower hearing thresholds are better than higher thresholds throughout the review. The review used the study authors' descriptions such as 'improvement' or 'deterioration' where available, however no interpretations were offered by many of the included studies.
Data were often presented only in figures and several studies did not report summary statistics such as means and measures of variance.
Although the air-conduction hearing aid may produce better audiometric results in some situations, it should be noted that the most appropriate hearing aid may not necessarily be the one with the best sound processing performance. Other factors such as comfort, the ability to wear the aid and reduced susceptibility to infections need to be considered, but these issues have not been adequately addressed by the included studies. Some included studies reported patient preference, however the tools used were not validated and likely to be biased, especially considering evidence that suggests individuals report preferring the second hearing aid tested, even if it is in fact an identical aid.
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Some data were available on the impact of BAHAs on quality of life. One study reported improvements with the Hearing Handicap and Disability Index but not the SF-36 or EQ-5D. The Hearing Handicap and Disability Index is specific to hearing loss, while the SF-36 and EQ-5D are generic measures that do not have a hearing dimension, which may explain the difference in outcomes between the different instruments.
Important issues related to comfort, discharge and pain are also not adequately addressed by the instruments.
It is therefore difficult to judge the impact of a BAHA on quality of life from these results.
Conclusions
In conclusion, the available evidence is methodologically weak and the results have a high risk of bias. As such, caution is indicated in the interpretation of results. However, based on the available evidence BAHAs appear to be a reasonable treatment option for people with bilateral conductive or mixed hearing loss. Further research into the benefits of BAHAs, including quality of life, is required. Whilst the BAHA intervention does not lend itself to randomised controlled trial study designs, waiting list control studies would be feasible. Further, a comprehensive approach to a number of issues would be beneficial, including: cost benefits, efficacy regarding audiometric measures, efficacy regarding disease control (e.g. reduced need for Otolaryngology input), and efficacy regarding patient perceived benefits.
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Figure 1 Flowchart of identification of studies
Lower hierarchy Excluded n = 26
Identified on searching (after duplicate removal) n = 665
Titles and abstracts inspected
Full papers retrieved n = 75
Full papers inspected
Potentially eligible n = 41
Included n = 12 (in 15 publications) → cohort pre-post design n = 7 → audiological comparison study n = 5
Excluded n = 562
Relevant nonEnglish papers n = 28
Excluded n =34
Hierarchy of study design examined and studies with BAHA models in current use identified 11.3 (6-17) Majority had symmetrical maximal or near-maximal conductive bilateral hearing loss. AC = air conduction; ACHA = air-conduction hearing aid; ACS = cross-sectional 'audiological comparison study'; BC = bone conduction; BCHA = bone-conduction hearing aid; CON= congenital aetiology, CPP = cohort pre and post study (one group before-and-after study); CSOM = chronic suppurative otitis media; F = female; M = male; NR = not reported; PTA = pure tone average. a There may be overlap of participants between these studies conducted in the UK. b Unaided condition was assessed pre and post-operatively and it is not clear which of these data are presented. c There may by overlap of participants between these studies conducted in The Netherlands. d 1 patient chose not to participate. Note: study authors' original terminology retained. SNR = signal-to-noise ratio; S 0 N 0 = in-phase tone stimuli and in-phase noise bands; S π N 0 = 180˚ out-of-phase tone stimuli and in-phase noise bands; S 0 N π = in-phase tone stimuli and 180˚ out-of-phase noise bands. a p<0.05 versus the chance level for that outcome. For correct localisation the chance level is 14.3%, (95% CI 32), for localisation within 30° the chance level is 42.9% (95% CI 64 ) and for lateralisation the chance level is 50% (95% CI 32). b For correct score, the chance level is 8.3%, for answers within 30° the chance level is 25%. c Relative threshold change in dB from the condition 'signal and noise in phase at both sides'. d For correct localisation score, the chance level is 20%, for lateralization score, the chance level is 68%. 
